An Update on the Classification and Pathologic Diagnosis of MGRS Lesions
The term monoclonal gammopathy of renal significance (MGRS) was introduced in 2012 by the International Kidney and Monoclonal Gammopathy Research Group. In 2019, the definition of MGRS, the diagnostic criteria, and classification for MGRS-related diseases were updated. At the end of this session, the participants will be able to classify renal diseases associated with MGRS, to list and discuss the entities recently included in the spectrum of MGRS-associated kidney diseases.
About the Speaker:
Dr. Samih H. Nasr
After graduating from Damascus University (Syria), Dr. Nasr completed his pathology residency and nephropathology fellowship at Columbia University, New York. He then served on the faculty at McGill University and Columbia University. He has published over 165 manuscripts, focusing on paraprotein-related kidney diseases and glomerular diseases with organized deposits, including amyloidosis and fibrillary glomerulonephritis.
To join the meeting go to: https://glomcon.zoom.us/ and select 'Join a Meeting'. Enter the Meeting ID into the web site (or connect directly from your Zoom app).
Meeting ID: 422-122-779
You HAVE to be logged into ZOOM to join the session. You may either create a free ZOOM account, or sign in through a Google or Facebook account (if you have one).
If you or your organization have Skype for Business (Lync), then you can also search and connect to us through::
Alternatively, use your institution's 'Polycom' system, enter IP address:
US West: 188.8.131.52
US East: 184.108.40.206
Then, enter the Meeting ID: 422-122-779
About the Seminars:
This new webinar series brings together two successful organizations with a common goal of improving and disseminating the knowledge of glomerular kidney diseases. The Renal Pathology Society promotes excellence in diagnosis and research and encourages training and education in renal disease to its members around the world. This series’ curriculum focuses on research in renal pathology and new technologies applied to renal pathology, including image analytics, machine learning, multi-‘omics, and computational pathology approaches to renal biopsy analyses. Through this collaboration with GlomCon, the RPS is committed to promoting excellence in the diagnosis of glomerular disease and to bringing the breakthrough innovations in this field to the GlomCon community, which as of May 2019 represents more than 2200 clinicians and pathologists from 108 countries.